Hepatitis B Virus Vaccines
Research from W.M. Xu and co-researchers in the area of hepatitis B virus vaccines published
Published in Hepatitis Weekly, February 16th, 2009
Research findings, 'Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study,' are discussed in a new report. According to recent research from Shanghai, People's Republic of China, "This randomized, double-blind, placebo-controlled study evaluated whether lamivudine given during late pregnancy can reduce hepatitis B virus (HBV) perinatal transmission in highly viraemic mothers. Mothers were randomized to either lamivudine 100 mg or placebo from week 32 of gestation to week 4 postpartum."
"At birth, infants received recombinant HBV vaccine with or without HBIg and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2009-02-16)
More Articles from Hepatitis Weekly
- Biopsy
Research from N. Dioguardi and co-researchers yields new findings on biopsy - Cancer
Study data from J. Gutierrezbanos and co-authors update knowledge of cancer - Cholangio Cancer
Research from H.B. Elserag and co-authors reveals new findings on cholangio cancer - Cholangio Cancer
Study results from Ege University, Medical Department provide new insights into cholangio cancer - Hepatitis
Research from University of Naples provides new data on hepatitis - Hepatitis
Research on hepatitis detailed by M. Kiran and co-authors - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
